Lipid extract from Antarctic Krill Euphausia superba as specified in Annex I, may be placed on the market in the Community as a novel food ingredient for the uses and at the maximum levels as listed in Annex II.
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647)
The designation ‘lipid extract from the crustacean Antarctic Krill Euphausia superba ’ shall be displayed on the labelling of the product as such or in the list of ingredients of foodstuffs containing it.
This Decision is addressed to Neptune Technologies & Bioressources Inc., 225 Promenade du Centropolis, Suite 200, Laval, Quebec H7T 0B3, Canada.
Schedules & Appendices
ANNEX I
SPECIFICATION OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA
Description
To produce lipid extract from Antarctic Krill Euphausia superba deep-frozen Antarctic krill is crushed and subjected to an extraction with acetone. Proteins and krill material are removed from the lipid extract by filtration. The acetone and residual water are removed by evaporation.
Test
Specification
Saponification value
Not more than 185 mg KOH/g
Peroxide value (PV)
Not more than 0,2 meq O 2 /kg oil
Moisture and volatiles
Not more than 0,9 %
Phospholipids
Not more than 50 %
Trans-fatty acids
Not more than 1 %
EPA (eicosapentaenoic acid)
Not less than 15 %
DHA (docosahexaenoic acid)
Not less than 7 %
ANNEX II
USES OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA
Use group
Maximum content of combined DHA and EPA
Dairy products except milk-based drinks
200 mg/100 g or for cheese products 600 mg/100 g
Dairy analogues except drinks
200 mg/100 g or for analogues to cheese products 600 mg/100 g
Spreadable fat and dressings
600 mg/100 g
Breakfast cereals
500 mg/100 g
Food supplements
200 mg per daily dose as recommended by the manufacturer
Dietary foods for special medical purposes
In accordance with the particular nutritional requirements of the persons for whom the products are intended
Foods intended for use in energy restricted diets for weight reduction
200 mg/meal replacement
Cite this act
2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32009D0752
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com